By [Your Name/Editorial Desk]
June 01, 2026
For decades, the discourse surrounding BRCA1 and BRCA2 genetic mutations has been almost exclusively framed through the lens of women’s health. Often dubbed "breast cancer genes," these mutations have become synonymous with screenings, mammograms, and the harrowing statistics regarding ovarian and breast cancer. However, this narrow narrative leaves a massive segment of the population vulnerable: men.
As cancer survivor and advocate Doug Bank argues, characterizing BRCA solely as a women’s issue is not just a medical oversight—it is a dangerous misconception that ignores the fundamental biological reality of genetic inheritance and cancer risk.
The Hidden Pattern: A Personal Chronology of Discovery
The journey toward understanding the male experience with BRCA is often marked by initial confusion and a late-arriving realization. For Doug Bank, the path began in his twenties, far removed from the world of genetic testing.
The Early Signs
At age 26, Bank was diagnosed with Stage I testicular cancer. At the time, his medical team did not link the diagnosis to genetic mutations, and he moved forward with surgery. However, the experience of navigating an overly aggressive post-surgical treatment protocol sparked a lifelong interest in patient advocacy. Bank went on to become a key figure in the LIVESTRONG Young Adult Alliance, where he first met Rochelle Shoretz, the founder of the organization Sharsheret. At the time, the intersection of his work and his personal life seemed distant.
Unraveling the Pedigree
It was only years later, during a routine family history review for his wife, that the necessity of genetic testing surfaced. When doctors inquired about Bank’s own family history, a clearer, more alarming picture emerged: a father with prostate cancer, an aunt with breast cancer, and a grandmother who succumbed to cancer at a young age.
When Bank finally consented to genetic testing, the result was a definitive BRCA2 mutation. A subsequent review of his family tree—what clinicians call a "pedigree"—revealed a generational pattern that had been hiding in plain sight: breast and ovarian cancers appearing across multiple branches of his father’s family.
A Multigenerational Impact
The gravity of this discovery hit home when Bank’s brother developed pancreatic cancer, a malignancy strongly associated with BRCA2 mutations. Though the diagnosis came too late to save him, the genetic knowledge allowed the family to navigate his final years with a clearer understanding of the disease.
The impact extended to the next generation. Despite initial resistance from medical professionals who argued that testing children was premature and anxiety-inducing, Bank persisted. His daughter, informed by her genetic status, remained vigilant. At age 24, she discovered a lump. Because she was already enrolled in a high-risk surveillance program, her diagnosis was caught early and treated effectively.
Supporting Data: Why Men Must Be Part of the Equation
The biological reality is straightforward: BRCA mutations are autosomal dominant, meaning they are passed down through a parent to a child regardless of gender. A man with a BRCA mutation has a 50% chance of passing it to each of his children, sons and daughters alike.
The Risks for Men
While women with BRCA mutations face the most well-known risks, men are at an elevated risk for several specific cancers:
- Prostate Cancer: Men with BRCA2 mutations are at a significantly higher risk of developing aggressive, early-onset prostate cancer.
- Male Breast Cancer: Though rare, the risk of breast cancer in men with BRCA2 mutations is approximately 100 times higher than that of the general male population.
- Pancreatic Cancer: Both BRCA1 and BRCA2 are associated with an increased risk of pancreatic cancer, which often carries a poor prognosis due to late detection.
- Melanoma: Some studies suggest a potential link between BRCA mutations and an increased risk of skin cancers.
The Knowledge Gap
Current medical literature suggests that many men remain unaware of their risk because they do not equate their family history of "women’s cancers" with their own health. According to the National Cancer Institute, men are less likely to undergo genetic counseling and testing than women, even when they have a known family history of hereditary cancer syndromes. This "testing gap" leaves thousands of men undiagnosed, unaware that they could be passing a high-risk mutation to their children.
Implications: Changing the Conversation
The implications of failing to engage men in the BRCA conversation are twofold: delayed detection in the men themselves and missed opportunities for the next generation.
Challenging the Stigma of "Anxiety"
One of the primary arguments used against early testing is the potential for psychological distress. However, as Bank notes, "not knowing does not make the risk go away." For many families, the uncertainty of a potential genetic risk is far more stressful than the clarity of a confirmed result. Once a mutation is identified, the focus shifts from "worry" to "actionable surveillance."
The Role of Genetic Counselors
Experts emphasize that genetic testing should not be a "DIY" endeavor. A genetic counselor plays a vital role in:
- Risk Assessment: Analyzing the family pedigree to determine if testing is appropriate.
- Informed Consent: Helping individuals understand the implications of the results for their siblings, children, and broader family.
- Long-term Strategy: Designing a personalized surveillance plan, such as annual prostate exams or pancreatic screenings, that would not be standard for the general population.
Official Perspectives: The Value of Specialized Support
Organizations like Sharsheret, which began as a support network for Jewish women facing breast and ovarian cancer, have expanded their reach to address the family-wide impact of hereditary cancer.
Bridging the Gender Divide
When organizations recognize that a cancer diagnosis is a family event, they become conduits for vital information. Men like Doug Bank, who serve on leadership councils, are helping to shift the culture. By sharing his own story of being diagnosed with prostate cancer at age 56, Bank provides a roadmap for other men to take ownership of their health.
Moving Forward
The consensus among advocates and oncologists is clear: the BRCA conversation must be expanded.
- For the Medical Community: Physicians must stop viewing BRCA as a "women’s health" topic. Intake forms and family history questionnaires should explicitly prompt men to report on both sides of the family tree.
- For Families: Communication is the most powerful tool for early detection. Sharing information about a mutation should be treated with the same urgency as any other serious health concern.
- For Men: Taking charge of one’s health involves acknowledging the vulnerability of the human genome. Whether you are a father, a brother, or a son, understanding your genetic footprint is an act of stewardship for the generations that follow.
"Men should not stand outside these conversations," Bank concludes. "We can carry the risk, pass it on, develop related cancers ourselves, help identify the pattern, and support our families when cancer enters the room."
As medical technology advances and genetic literacy improves, the hope is that the stigma surrounding these mutations will evaporate. In its place, a culture of proactive health management must rise—one where men are not just bystanders, but informed, empowered participants in their family’s health legacy.
About the Author
